Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Post by Trader7771on Jun 25, 2008 2:16pm
301 Views
Post# 15228415

NEWS

NEWS


Bluerock and Uranerz Sell Mongolia Assets to Jindal Steel & Power for USD $2.6 Million
Tuesday June 24, 8:30 am ET


VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 24, 2008) - Bluerock Resources Ltd. ("Bluerock") (TSX VENTURE:BRD - News)and Uranerz Energy Corporation ("Uranerz") (or jointly "the Companies")announce that they have arranged for the sale of 100% of theirMongolian Joint Venture project to Jindal Steel & Power (Mauritius)Limited ("Jindal") for USD $2.6 million. The Mongolian JV assets weredeemed to be noncore by both Bluerock and Uranerz as they focus ontheir respective near term production development projects in thecontinental USA.


Thesale includes all Mongolian uranium exploration projects and existingmaterial assets the Companies maintain in Mongolia. Jindal has untilAugust 26th, 2008 to conduct its due diligence review and close theagreement. Significant technical and financial review has already beencompleted by Jindal.

Bluerock has been acting as the operator ofthe Mongolian JV with Uranerz for the past three (3) years and wasmaterially involved in the negotiation of this transaction with Jindal.Under the terms of the JV, Bluerock holds a 60% ownership and Uranerzholds the remaining 40% (See the Company News Release of April 1,2008). Bluerock spent the 2006 and 2007 seasons advancing the MongolianJV Project, which resulted in several significant discoveries (See NewsRelease of January 22, 2008).

"The sale of Bluerock's Mongolianexploration arm is a timely step for Bluerock as it allows the Companyto monetize the exploration results over the last two field seasons andredirect these funds towards Bluerock's main focus, our Southwest USuranium mining projects," President Michael Collins commented."Bluerock remains focused on building production, and in the groundresources in Colorado and Utah to support the Company's on-going planof becoming the next uranium producer in the United States."

BluerockResources Ltd. is a uranium mining company focused on developingtomorrow's energy today through the acquisition and development ofconventional uranium resources.

ON BEHALF OF THE BOARD OF DIRECTORS

Michael Collins, President and CEO

Bullboard Posts